Rossari Biotech Limited (ROSSARI) — Board Meeting

1 Board Meeting 🟡 Notable Neutral 📄 PDF

📢 Key Event
All 8 resolutions passed at the 17th AGM with near-unanimous shareholder approval.

💡 Investor Takeaway
Shareholders overwhelmingly endorsed the company's financials and governance, signaling strong confidence in management.

Rossari Biotech held its 17th AGM on July 20, 2026 via video conferencing, where all 8 resolutions were passed with overwhelming shareholder approval. E-voting saw 82,558,438 votes in favor and just 13,101 against, reflecting near-unanimous support. The meeting concluded at 12:08 PM IST after starting at 11:00 AM, with quorum met electronically. Shareholders approved the audited financial statements, appointed statutory auditors, and declared a dividend of ₹0.50 per share payable within 10 working days. Statutory and secretarial audit reports were confirmed available. The company confirmed compliance with all regulatory norms, including exclusion of promoter votes and proper documentation of voting records.

2 Board Meeting 🟡 Notable Neutral 📄 PDF

📢 Key Event
Correction of ESOP grant number from 4000 to 5000 options in board announcement

🔄 What Changed
Number of options granted updated from 4000 to 5000

💡 Investor Takeaway
The correction ensures accurate ESOP disclosure without altering the grant's substance or impact on shareholders.

Rossari Biotech corrected a typographical error in its July 18 board meeting announcement, changing the number of employee stock options granted from 4000 to 5000 in Annexure I, while confirming all other details remain unchanged, ensuring accurate disclosure of the ESOP grant to investors and regulators.

📊 Stock Analysis — ROSSARI ✨ Ask AI About This